Children and adults with rare forms of cystic fibrosis in England will be able to access triple-combination therapy. Vanzacaftor–tezacaftor–deutivacaftor (Alyftrek®), is the latest in a new generation ...

Charles Kim Haskell told Newsweek he once thought he wouldn't live beyond his teenage years, but, at 31, he is enjoying his life.

The Cystic Fibrosis Foundation has agreed to provide Prime Medicine Inc. an additional investment of up to $24 million to ...

Licensed for use in the UK in March, Alyftrek will now be immediately funded by the NHS in England. This rapid timeline demonstrates NICE's commitment to getting breakthrough treatments to patients ...

Latest studies show Us pharma giant Vertex's new CF wonder pill Alyftrek has shown better results than their currently available drug Kaftrio.

Today, the Cystic Fibrosis Foundation announced an additional investment of up to $24 million in Prime Medicine to continue the development of a gene editing therapy for people with cystic fibrosis ...

Perimenopause occurs before menopause, and may last for several years. Learn more about the early signs of perimenopause.